Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation

    In this retrospective analysis using the Transplant Registry Unified Management Program, we identified 145 patients with human herpesvirus (HHV)-6 encephalitis among 6593 recipients. The cumulative incidences ...

    M Ogata, K Oshima, T Ikebe, K Takano, H Kanamori, T Kondo in Bone Marrow Transplantation (2017)

  2. No Access

    Article

    Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation

    HLA 1-locus-mismatched unrelated donors (1MMUD) have been used in allogeneic hematopoietic stem cell transplantation (allo-HCT) for patients who lack an HLA-matched donor. We retrospectively analyzed 3313 pati...

    K Kawamura, J Kanda, S Fuji, M Murata, K Ikegame, K Yoshioka in Bone Marrow Transplantation (2017)

  3. No Access

    Article

    GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia

    To investigate better GVHD prophylaxis in reduced intensity conditioning umbilical cord blood transplantation (RIC-UCBT), we compared transplant outcomes after UCBT among GvHD prophylaxes using the registry da...

    S Terakura, Y Kuwatsuka, S Yamasaki, A Wake, J Kanda in Bone Marrow Transplantation (2017)

  4. No Access

    Article

    A phase I/II trial of intrabone marrow cord blood transplantation and comparison of the hematological recovery with the Japanese nationwide database

    Intrabone marrow cord blood transplantation (IB-CBT) was proposed as a promising treatment modality to improve hematological recovery. However, clinical advantages of IB-CBT over conventional IV CBT have been ...

    N Kurita, M Gosho, Y Yokoyama, T Kato, N Obara in Bone Marrow Transplantation (2017)

  5. No Access

    Article

    Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation

    The effect of graft-versus-host disease (GVHD) on transplant outcomes after unrelated cord blood transplantation (UCBT) has not been fully elucidated. We analyzed the impact of acute and chronic GVHD on outcom...

    J Kanda, Y Morishima, S Terakura, A Wake, N Uchida, S Takahashi, Y Ono in Leukemia (2017)

  6. No Access

    Article

    Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study

    H Fujiwara, S Fuji, A Wake, K Kato, Y Takatsuka, T Fukuda in Bone Marrow Transplantation (2017)

  7. No Access

    Article

    Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil

    In order to examine GvHD prophylaxis in umbilical cord blood transplantation (UCBT) in more detail, we compared transplant outcomes after UCBT for acute leukemia among GvHD prophylaxes using registry data. We ...

    S Terakura, A Wake, Y Inamoto, M Murata, R Sakai in Bone Marrow Transplantation (2017)

  8. No Access

    Article

    Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT

    A nationwide retrospective study for the clinical outcomes of 99 patients who had received thymoglobulin at a median total dose of 2.5 mg/kg (range, 0.5–18.5 mg/kg) as a second-line treatment for steroid-resis...

    M Murata, K Ikegame, Y Morishita, H Ogawa, K Kaida in Bone Marrow Transplantation (2017)

  9. No Access

    Article

    High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study

    Y Arai, T Kondo, A Shigematsu, J Tanaka, S Takahashi in Bone Marrow Transplantation (2016)

  10. No Access

    Article

    Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation

    M Kato, T Yamashita, R Suzuki, K Matsumoto, H Nishimori, S Takahashi, K Iwato in Leukemia (2016)

  11. Article

    Open Access

    All-trans retinoic acid and interferon-α increase CD38 expression on adult T-cell leukemia cells and sensitize them to T cells bearing anti-CD38 chimeric antigen receptors

    K Mihara, T Yoshida, S Ishida, Y Takei, A Kitanaka, K Shimoda in Blood Cancer Journal (2016)

  12. No Access

    Article

    Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes

    This retrospective study was conducted in Japan to determine the incidence, risk factors and outcomes of sinusoidal obstruction syndrome (SOS) after allogeneic hematopoietic stem cell transplantation (HSCT). A...

    K Yakushi**, Y Atsuta, N Doki, A Yokota, H Kanamori in Bone Marrow Transplantation (2016)

  13. No Access

    Article

    Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma

    Allogeneic hematopoietic SCT (allo-HSCT) is a curative treatment for aggressive adult T-cell leukemia/lymphoma (ATLL). Considering the dismal prognosis associated with conventional chemotherapies, early applic...

    S Fuji, H Fujiwara, N Nakano, A Wake, Y Inoue, T Fukuda in Bone Marrow Transplantation (2016)

  14. No Access

    Article

    Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation

    The impact of the conditioning intensity and TBI on acute GVHD (aGVHD) is still a matter of debate. We analyzed 6848 adult recipients who received allogeneic hematopoietic cell transplants (HCT) between 2006 a...

    H Nakasone, T Fukuda, J Kanda, T Mori, S Yano, T Kobayashi in Bone Marrow Transplantation (2015)

  15. Article

    Open Access

    Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma

    T Mino, K Mihara, T Yoshida, Y Takihara, T Ichinohe in Blood Cancer Journal (2014)

  16. No Access

    Article

    Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT

    In unrelated hematopoietic SCT (HSCT), HLA allele mismatch has been shown to have a significant role. To clarify the importance of HLA allele mismatch in the GVH direction in related HSCT, we retrospectively e...

    S Fuji, J Kanda, S Kato, K Ikegame, S Morishima, T Miyamoto in Bone Marrow Transplantation (2014)

  17. No Access

    Article

    Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction

    Little information is available regarding whether an unrelated cord blood (UCB) unit or a related donor with a 1-antigen mismatch at the HLA-A, HLA-B or HLA-DR locus in the graft-versus-host direction (RD/1AG-...

    J Kanda, T Ichinohe, S Kato, N Uchida, S Terakura, T Fukuda, M Hidaka, Y Ueda in Leukemia (2013)

  18. No Access

    Article

    Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation

    Although fluoroquinolones or other antibiotics are commonly used to prevent bacterial infections after hematopoietic cell transplantation (HCT), because of the growing presence of multidrug-resistant microorga...

    J Kanda, C Mizumoto, T Ichinohe, H Kawabata, T Saito in Bone Marrow Transplantation (2011)

  19. No Access

    Article

    Impact of discontinuing fluoroquinolone prophylaxis on early mortality after allogeneic marrow or peripheral blood SCT with myeloablative conditioning

    J Kanda, T Ichinohe, T Saito, K Yamashita, T Kondo in Bone Marrow Transplantation (2010)

  20. No Access

    Article

    Long-term survival after HLA-haploidentical SCT from noninherited maternal antigen-mismatched family donors: impact of chronic GVHD

    J Kanda, T Ichinohe, C Shimazaki, M Hamaguchi, A Watanabe in Bone Marrow Transplantation (2009)

previous disabled Page of 2